Supernus Pharmaceuticals (SUPN) News Today $44.88 +1.56 (+3.60%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$46.88 +2.00 (+4.45%) As of 08/22/2025 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SUPN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Supernus Pharmaceuticals, Inc. $SUPN Shares Bought by Invesco Ltd.August 24 at 3:30 AM | marketbeat.comCritical Analysis: Supernus Pharmaceuticals (NASDAQ:SUPN) and Taysha Gene Therapies (NASDAQ:TSHA)August 24 at 2:11 AM | americanbankingnews.comSupernus Pharmaceuticals (NASDAQ:SUPN) Upgraded by Zacks Research to Hold RatingAugust 23 at 7:37 AM | marketbeat.comEntryPoint Capital LLC Buys New Shares in Supernus Pharmaceuticals, Inc. $SUPNAugust 23 at 6:21 AM | marketbeat.comSupernus Pharmaceuticals, Inc. $SUPN Holdings Lowered by Charles Schwab Investment Management Inc.August 23 at 3:55 AM | marketbeat.comVanguard Group Inc. Buys 13,133 Shares of Supernus Pharmaceuticals, Inc. $SUPNAugust 22 at 3:18 AM | marketbeat.com1 Small-Cap Stock with Competitive Advantages and 2 We Brush OffAugust 21 at 4:32 PM | msn.comBethany Sensenig Sells 5,369 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) StockAugust 20, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Director Frederick M. Hudson Sells 7,457 SharesAugust 20, 2025 | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Sets New 1-Year High - Here's What HappenedAugust 20, 2025 | marketbeat.comInsider Decision: Frederick Hudson Offloads $315K Worth Of Supernus Pharmaceuticals StockAugust 20, 2025 | benzinga.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Director Sells $226,840.25 in StockAugust 19, 2025 | insidertrades.comInsider Sell: Bethany Sensenig Sells 5,369 Shares of Supernus Pharmaceuticals Inc (SUPN)August 18, 2025 | gurufocus.comWinners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals StocksAugust 18, 2025 | msn.comPublic Sector Pension Investment Board Purchases 82,167 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)August 16, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Lowers Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)August 14, 2025 | marketbeat.comStatutory Profit Doesn't Reflect How Good Supernus Pharmaceuticals' (NASDAQ:SUPN) Earnings AreAugust 13, 2025 | uk.finance.yahoo.com5 Insightful Analyst Questions From Supernus Pharmaceuticals’s Q2 Earnings CallAugust 13, 2025 | msn.comSUPN Q2 Deep Dive: Growth Drivers Shift to New Portfolio as Legacy Products FadeAugust 13, 2025 | finance.yahoo.comHere’s Third Avenue Small-Cap Value Fund’s Update on Supernus Pharmaceuticals (SUPN)August 11, 2025 | insidermonkey.comReflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Royalty Pharma (NASDAQ:RPRX)August 11, 2025 | msn.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) CEO Sells $5,882,800.00 in StockAugust 10, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) CEO Jack A. Khattar Sells 140,000 SharesAugust 9, 2025 | insidertrades.comSupernus Pharmaceuticals Stock Scores RS Rating UpgradeAugust 8, 2025 | msn.comSupernus Pharmaceuticals Scores Relative Strength Rating Upgrade; Hits Key ThresholdAugust 7, 2025 | msn.comSupernus Pharmaceuticals (NASDAQ:SUPN) Sets New 1-Year High on Analyst UpgradeAugust 7, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Forecast for Supernus Pharmaceuticals (NASDAQ:SUPN) Stock PriceAugust 7, 2025 | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Issues Quarterly Earnings ResultsAugust 6, 2025 | marketbeat.comSupernus Pharmaceuticals (SUPN) Price Target Raised by Cantor Fitzgerald | SUPN Stock NewsAugust 6, 2025 | gurufocus.comStocks With Rising Relative Strength: Supernus PharmaceuticalsAugust 6, 2025 | msn.comSupernus Pharmaceuticals (NASDAQ:SUPN) Beats Expectations in Strong Q2, Guides for Strong Full-Year SalesAugust 6, 2025 | finance.yahoo.comSupernus Pharmaceuticals Inc (SUPN) Q2 2025 Earnings Call Highlights: Innovation and Strategic ...August 6, 2025 | gurufocus.comSupernus Pharmaceuticals, Inc. (SUPN) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comSupernus Announces Second Quarter 2025 Financial ResultsAugust 5, 2025 | globenewswire.comArkadios Wealth Advisors Invests $550,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)August 5, 2025 | marketbeat.comJefferies Financial Group Inc. Purchases 56,713 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)August 4, 2025 | marketbeat.comSupernus Pharmaceuticals (SUPN) Reports Earnings Tomorrow: What To ExpectAugust 4, 2025 | finance.yahoo.comSupernus Pharmaceuticals (NASDAQ:SUPN) Raised to "Buy" at Wall Street ZenAugust 3, 2025 | marketbeat.comSupernus Pharmaceuticals Completes Acquisition of Sage TherapeuticsJuly 31, 2025 | tipranks.comSupernus Pharmaceuticals Completes Acquisition of Sage TherapeuticsJuly 31, 2025 | globenewswire.comSupernus Pharmaceuticals (NASDAQ:SUPN) Upgraded by Cantor Fitzgerald to "Overweight" RatingJuly 31, 2025 | marketbeat.com65,585 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Purchased by Universal Beteiligungs und Servicegesellschaft mbHJuly 31, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Could Be 50% Below Their Intrinsic Value EstimateJuly 30, 2025 | finance.yahoo.comWhy Supernus Pharmaceuticals (SUPN) Stock Is Up TodayJuly 30, 2025 | msn.comSupernus Pharmaceuticals (SUPN) Projected to Post Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Purchased by GSA Capital Partners LLPJuly 29, 2025 | marketbeat.comRoyce & Associates LP Boosts Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 29, 2025 | marketbeat.comSupernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender OfferJuly 28, 2025 | globenewswire.comPacer Advisors Inc. Has $13.22 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 27, 2025 | marketbeat.comBranded Pharmaceuticals Stocks Q1 Recap: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)July 25, 2025 | msn.com Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address SUPN Media Mentions By Week SUPN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SUPN News Sentiment▼0.930.69▲Average Medical News Sentiment SUPN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SUPN Articles This Week▼176▲SUPN Articles Average Week Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CORT News JAZZ News PRGO News PCRX News NKTR News OMER News ASMB News CPIX News LLY News JNJ News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SUPN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access